Persistent reduction of spinal inflammation as assessed by magnetic resonance imaging in patients with ankylosing spondylitis after 2 yrs of treatment with the anti-tumour necrosis factor agent infliximab - Sieper, J; Baraliakos, X; Listing, J (Rheumatology (Oxford), 2005)
et al.